Period,symbol,NAV,sharesOutstanding,researchDevelopment,effectOfAccountingCharges,incomeBeforeTax,minorityInterest,netIncome,sellingGeneralAdministrative,grossProfit,ebit,operatingIncome,otherOperatingExpenses,interestExpense,extraordinaryItems,nonRecurring,otherItems,incomeTaxExpense,totalRevenue,totalOperatingExpenses,costOfRevenue,totalOtherIncomeExpenseNet,discontinuedOperations,netIncomeFromContinuingOps,netIncomeApplicableToCommonShares,intangibleAssets,capitalSurplus,totalLiab,totalStockholderEquity,otherCurrentLiab,totalAssets,commonStock,retainedEarnings,otherAssets,cash,totalCurrentLiabilities,deferredLongTermAssetCharges,propertyPlantEquipment,totalCurrentAssets,netReceivables,inventory,accountsPayable,changeToLiabilities,totalCashflowsFromInvestingActivities,totalCashFromFinancingActivities,changeToOperatingActivities,issuanceOfStock,changeInCash,repurchaseOfStock,totalCashFromOperatingActivities,depreciation,changeToInventory,changeToAccountReceivables,changeToNetincome,capitalExpenditures,WC,language,region,quoteType,triggerable,quoteSourceName,averageDailyVolume10Day,fiftyTwoWeekLowChange,fiftyTwoWeekLowChangePercent,fiftyTwoWeekRange,fiftyTwoWeekHighChange,fiftyTwoWeekHighChangePercent,fiftyTwoWeekLow,fiftyTwoWeekHigh,earningsTimestamp,earningsTimestampStart,earningsTimestampEnd,trailingPE,bookValue,fiftyDayAverage,fiftyDayAverageChange,fiftyDayAverageChangePercent,twoHundredDayAverage,twoHundredDayAverageChange,marketCap,forwardPE,priceHint,regularMarketChangePercent,priceToBook,sourceInterval,exchangeTimezoneName,exchangeTimezoneShortName,gmtOffSetMilliseconds,regularMarketDayRange,regularMarketPreviousClose,bid,ask,bidSize,askSize,messageBoardId,fullExchangeName,longName,financialCurrency,averageDailyVolume3Month,priceEpsCurrentYear,currency,esgPopulated,tradeable,regularMarketPrice,regularMarketTime,regularMarketChange,regularMarketOpen,regularMarketDayHigh,regularMarketDayLow,regularMarketVolume,exchange,shortName,exchangeDataDelayedBy,market,marketState,epsTrailingTwelveMonths,epsForward,epsCurrentYear,twoHundredDayAverageChangePercent,Beta (5Y Monthly),52-Week Change 3,S&P500 52-Week Change 3,52 Week High 3,52 Week Low 3,50-Day Moving Average 3,200-Day Moving Average 3,Avg Vol (3 month) 3,Avg Vol (10 day) 3,Shares Outstanding 5,Implied Shares Outstanding 6,Float,% Held by Insiders 1,% Held by Institutions 1,"Shares Short (Aug 12, 2021) 4","Short Ratio (Aug 12, 2021) 4","Short % of Float (Aug 12, 2021) 4","Short % of Shares Outstanding (Aug 12, 2021) 4","Shares Short (prior month Jul 14, 2021) 4",Forward Annual Dividend Rate 4,Forward Annual Dividend Yield 4,Trailing Annual Dividend Rate 3,Trailing Annual Dividend Yield 3,5 Year Average Dividend Yield 4,Payout Ratio 4,Dividend Date 3,Ex-Dividend Date 4,Last Split Factor 2,Last Split Date 3,Fiscal Year Ends,Most Recent Quarter (mrq),Profit Margin,Operating Margin (ttm),Return on Assets (ttm),Return on Equity (ttm),Revenue (ttm),Revenue Per Share (ttm),Quarterly Revenue Growth (yoy),Gross Profit (ttm),EBITDA,Net Income Avi to Common (ttm),Diluted EPS (ttm),Quarterly Earnings Growth (yoy),Total Cash (mrq),Total Cash Per Share (mrq),Total Debt (mrq),Total Debt/Equity (mrq),Current Ratio (mrq),Book Value Per Share (mrq),Operating Cash Flow (ttm),Levered Free Cash Flow (ttm),index,zip,sector,fullTimeEmployees,compensationRisk,auditRisk,longBusinessSummary,city,phone,state,shareHolderRightsRisk,compensationAsOfEpochDate,governanceEpochDate,boardRisk,country,website,maxAge,overallRisk,address1,fax,industry
t0,ELMD,31753000,8635040,326245,,649540,,399540,5953129,6930683,651309,651309,,,,,,250000,9468783,8817474,2538100,-1769,,399540,399540,663000,17409000,4693000,32416000,1228000,37109000,85000,14922000,1049000,11889000,4639000,1049000,3693000,31704000,17425000,2114000,685000,64571,-239869,-1123837,219616,331,-611538,-1124168,752168,152555,132253,-630104,-127999,-181528,27065000,en-US,US,EQUITY,True,Nasdaq Real Time Price,30616,4.245,0.524074,8.1 - 12.88,-0.53499985,-0.041537255,8.1,12.88,1620763200,1620763200,1620763200,30.109756,3.744,11.670834,0.6741667,0.057765085,10.910362,1.434638,106599568,25.718752,2,-0.6838297,3.2972758,15,America/New_York,EDT,-14400000,12.345 - 12.44,12.43,12.2,12.49,8,10,finmb_104752926,NYSE American,"Electromed, Inc.",USD,62979,45.72222,USD,False,False,12.345,1630507925,-0.08500004,12.4,12.44,12.345,2074,ASE,"Electromed, Inc.",0,us_market,REGULAR,0.41,0.48,0.27,0.13149317,0.66,,,12.88,8.1,11.67,10.91,62.98k,30.62k,8.64M,,6.27M,17.60%,46.03%,103.99k,3.84,1.45%,1.20%,133.98k,,,,,,0.00%,,,,,"Jun 29, 2021","Jun 29, 2021",6.61%,8.78%,5.58%,7.54%,35.76M,4.17,37.70%,27.3M,3.75M,2.36M,0.41,-69.50%,11.89M,1.39,87k,0.27,6.83,3.74,3.08M,2.57M,Value,56071,Healthcare,132,8,9,"Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.",New Prague,952 758 9299,MN,6,1609372800,1625097600,5,United States,http://smartvest.com,86400,7,500 Sixth Avenue NW,866 758 5077,Medical Devices
t-1,ELMD,32270181,8635040,407199,,252771,,223771,6050666,6700852,242987,242987,,,,,,29000,8786972,8543985,2086120,9784,,223771,223771,602430,17140274,4297952,32872611,740000,37170563,86374,15645963,653000,12500688,4238250,653000,3626951,32288182,17048083,2256012,1023603,725000,-64263,-11117,-76545,331,758573,-11117,833953,141882,348317,-702075,351223,-51694,28049932,en-US,US,EQUITY,True,Nasdaq Real Time Price,30616,4.245,0.524074,8.1 - 12.88,-0.53499985,-0.041537255,8.1,12.88,1620763200,1620763200,1620763200,30.109756,3.744,11.670834,0.6741667,0.057765085,10.910362,1.434638,106599568,25.718752,2,-0.6838297,3.2972758,15,America/New_York,EDT,-14400000,12.345 - 12.44,12.43,12.2,12.49,8,10,finmb_104752926,NYSE American,"Electromed, Inc.",USD,62979,45.72222,USD,False,False,12.345,1630507925,-0.08500004,12.4,12.44,12.345,2074,ASE,"Electromed, Inc.",0,us_market,REGULAR,0.41,0.48,0.27,0.13149317,0.66,,,12.88,8.1,11.67,10.91,62.98k,30.62k,8.64M,,6.27M,17.60%,46.03%,103.99k,3.84,1.45%,1.20%,133.98k,,,,,,0.00%,,,,,"Jun 29, 2021","Jun 29, 2021",6.61%,8.78%,5.58%,7.54%,35.76M,4.17,37.70%,27.3M,3.75M,2.36M,0.41,-69.50%,11.89M,1.39,87k,0.27,6.83,3.74,3.08M,2.57M,Value,56071,Healthcare,132,8,9,"Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.",New Prague,952 758 9299,MN,6,1609372800,1625097600,5,United States,http://smartvest.com,86400,7,500 Sixth Avenue NW,866 758 5077,Medical Devices
t-2,ELMD,31711037,8635040,507497,,1592427,,1203427,5435025,7525243,1582721,1582721,,,,,,389000,9496073,7913352,1970830,9706,,1203427,1203427,622697,16825192,3489890,32333734,770000,35823624,86350,15422192,678000,11742115,3485961,678000,3627166,30895761,16168388,2603495,722905,-6488,-62362,-7633,122314,45669,598934,-53302,668929,152136,463496,-1668491,260581,-38007,27409800,en-US,US,EQUITY,True,Nasdaq Real Time Price,30616,4.245,0.524074,8.1 - 12.88,-0.53499985,-0.041537255,8.1,12.88,1620763200,1620763200,1620763200,30.109756,3.744,11.670834,0.6741667,0.057765085,10.910362,1.434638,106599568,25.718752,2,-0.6838297,3.2972758,15,America/New_York,EDT,-14400000,12.345 - 12.44,12.43,12.2,12.49,8,10,finmb_104752926,NYSE American,"Electromed, Inc.",USD,62979,45.72222,USD,False,False,12.345,1630507925,-0.08500004,12.4,12.44,12.345,2074,ASE,"Electromed, Inc.",0,us_market,REGULAR,0.41,0.48,0.27,0.13149317,0.66,,,12.88,8.1,11.67,10.91,62.98k,30.62k,8.64M,,6.27M,17.60%,46.03%,103.99k,3.84,1.45%,1.20%,133.98k,,,,,,0.00%,,,,,"Jun 29, 2021","Jun 29, 2021",6.61%,8.78%,5.58%,7.54%,35.76M,4.17,37.70%,27.3M,3.75M,2.36M,0.41,-69.50%,11.89M,1.39,87k,0.27,6.83,3.74,3.08M,2.57M,Value,56071,Healthcare,132,8,9,"Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.",New Prague,952 758 9299,MN,6,1609372800,1625097600,5,United States,http://smartvest.com,86400,7,500 Sixth Avenue NW,866 758 5077,Medical Devices
t-3,ELMD,30229269,8635040,481059,,672262,,535262,5004179,6148221,662983,662983,,,,,,137000,8004171,7341188,1855950,9279,,535262,535262,626747,16551189,3534776,30856016,750000,34390792,86062,14218765,700000,11143181,3528775,700000,3726609,29337436,14641851,3065043,766197,500917,-81506,-76413,-114385,45669,664031,-76413,821950,163427,26934,-580330,246195,-15771,25808661,en-US,US,EQUITY,True,Nasdaq Real Time Price,30616,4.245,0.524074,8.1 - 12.88,-0.53499985,-0.041537255,8.1,12.88,1620763200,1620763200,1620763200,30.109756,3.744,11.670834,0.6741667,0.057765085,10.910362,1.434638,106599568,25.718752,2,-0.6838297,3.2972758,15,America/New_York,EDT,-14400000,12.345 - 12.44,12.43,12.2,12.49,8,10,finmb_104752926,NYSE American,"Electromed, Inc.",USD,62979,45.72222,USD,False,False,12.345,1630507925,-0.08500004,12.4,12.44,12.345,2074,ASE,"Electromed, Inc.",0,us_market,REGULAR,0.41,0.48,0.27,0.13149317,0.66,,,12.88,8.1,11.67,10.91,62.98k,30.62k,8.64M,,6.27M,17.60%,46.03%,103.99k,3.84,1.45%,1.20%,133.98k,,,,,,0.00%,,,,,"Jun 29, 2021","Jun 29, 2021",6.61%,8.78%,5.58%,7.54%,35.76M,4.17,37.70%,27.3M,3.75M,2.36M,0.41,-69.50%,11.89M,1.39,87k,0.27,6.83,3.74,3.08M,2.57M,Value,56071,Healthcare,132,8,9,"Electromed, Inc. develops, manufactures, markets, and sells airway clearance therapy and related products that apply high frequency chest wall oscillation (HFCWO) therapy in pulmonary care for patients of various ages in the United States and internationally. The company offers SmartVest airway clearance system; SmartVest SQL System that consists of an inflatable therapy garment, a programmable air pulse generator, and a patented single-hose that delivers air pulses from the generator to the garment; and SmartVest Connect, a wireless technology with personalized HFCWO therapy management portal for patients with compromised pulmonary function. It also provides single patient use SmartVest and SmartVest Wrap products for health care providers in the acute care setting. The company offers its products primarily to home health care market for patients with bronchiectasis, cystic fibrosis, and neuromuscular disease. Electromed, Inc. markets its products primarily to physicians and health care providers, as well as directly to patients. The company was incorporated in 1992 and is headquartered in New Prague, Minnesota.",New Prague,952 758 9299,MN,6,1609372800,1625097600,5,United States,http://smartvest.com,86400,7,500 Sixth Avenue NW,866 758 5077,Medical Devices
